Could This Hot Growth Stock Be the Next MercadoLibre? Why It Looks Like a Screaming Buy

BBB Foods (Tiendas 3B) reported 20% same-store sales growth in Q2, alongside continued store expansion to 3,624 locations and a long-term target of 12,000 stores in Mexico. Profitability is highlighted with EBITDA of 960 million Ps on 26 billion Ps of revenue (about $1.53B revenue), supporting a valuation framed at ~1.1x price-to-sales. Overall, the strong comparable growth and profitability suggest continued operating momentum, though broader valuation and IFRS losses imply execution risk.

Analysis

BBB Foods is starting to look less like a “growth story” and more like a channel-formation event in Mexican grocery. The real implication is pressure on the middle of the market: regional supermarkets and mom-and-pop stores lose traffic first, then branded CPGs face forced pack-size and pricing concessions as private label expands its shelf share. If the company can keep same-store momentum while opening stores, unit economics are likely strong enough to self-fund expansion; if not, the market will quickly reclassify this as a capital-intensive roll-up rather than a moat business.

Near term, the critical variable is not store count but new-store productivity versus cannibalization. Rapid expansion can mask weakening underlying demand, so watch traffic, basket size, gross margin, and shrink over the next 1-3 quarters; a deceleration in comp sales into the low teens would likely compress the multiple even if top-line growth remains high. The biggest second-order beneficiary may be local private-label suppliers and logistics players, while the main loser is the broad supermarket complex, especially firms with larger box formats and higher cost bases.

The consensus is probably extrapolating the 12,000-store target too linearly. Hard-discount models tend to look invincible until labor, real estate, and distribution density become the binding constraints; that risk is 6-18 months out, not next week. The contrarian setup is that the stock may be cheaper than headline growth suggests because the market is discounting IFRS losses, but the reverse is also true: if growth normalizes after the rollout phase, the valuation can re-rate down fast. Falsify the bullish case if comp sales fall below ~10%, EBITDA margins stall, or management slows openings due to weaker unit returns.

Key Decisions for Investors

• Long TBBB on 1-3 month weakness, but size modestly: the setup is attractive if comp sales stay >15% and store openings remain disciplined; thesis breaks if gross margin or traffic deteriorate in the next two earnings prints.
• Pair trade: long TBBB / short WMT over 3-6 months to express Mexican discount-channel share shift and margin pressure on traditional retail; hedge is imperfect, but it isolates the winner/loser dynamic better than a market-direction bet.
• Set a watch alert on TBBB for any comp-sales deceleration below 10% or guidance for slower new-store productivity; that would be the first sign the market is overpricing the 12,000-store narrative.
• Avoid chasing the stock after sharp upside gaps; prefer entries after post-earnings volatility when the market has had a chance to reprice lease-heavy expansion risk.
• If you want lower beta exposure to the same consumer-upgrade theme, favor MELI over TBBB as the higher-quality LatAm compounder; TBBB has better near-term operating torque but materially higher execution risk.